Shares float of BioAmber Inc.
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers primarily in the United States and Canada. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company's bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing solutions, PET resins, lubricants, polybutylene succinate, fine chemicals, and food additives. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol and tetrahydrofuran used in elastomers, engineering plastics, shoe soles, spandex, and solvents; succinic acid based polyesters for use in automotive interiors, fibers and non-wovens, food packaging, plastic bags and cups, and organic composite boards; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine used in carpets, engineering plastics, textiles and fibers, films, and polyurethanes. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.
|CALA Calithera Biosciences, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-$27.1M|
|PIRS Pieris Pharmaceuticals, Inc.||NASDAQ > Health Care > Biotechnology: Commercial Physical & Biological Resarch||-$27M|
|EKSO Ekso Bionics Holdings, Inc.||NASDAQ > Capital Goods > Industrial Machinery/Components||-$26.6M|
|LQDT Liquidity Services, Inc.||NASDAQ > Miscellaneous > Business Services||-$26.4M|
|AGLE Aeglea BioTherapeutics, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-$26.4M|
|TLND Talend S.A.||NASDAQ > Technology > Computer Software: Prepackaged Software||-$26.3M|
|BIOA BioAmber Inc.||NYSE > Basic Industries > Major Chemicals||-$26.2M|
|CHL China Mobile (Hong Kong) Ltd.||NYSE > Public Utilities > Telecommunications Equipment||$42.5B|
|PTR PetroChina Company Limited||NYSE > Energy > Oil & Gas Production||$43.1B|
|VZ Verizon Communications Inc.||NYSE > Public Utilities > Telecommunications Equipment||$44.4B|
|VZA Verizon Communications Inc.||NYSE > Public Utilities > Telecommunications Equipment||$44.4B|
|T AT&T Inc.||NYSE > Public Utilities > Telecommunications Equipment||$48.2B|
|AAPL Apple Inc.||NASDAQ > Technology > Computer Manufacturing||$74.2B|